MRK

Merck & Co., Inc. (NYSE: MRK) Q2 2025 Earnings Call dated Jul. 29, 2025 Corporate Participants: Peter Dannenbaum — Senior…

Merck & Co., Inc. (NYSE: MRK) Q3 2025 Earnings Call dated Oct. 30, 2025 Corporate Participants: Peter Dannenbaum — Senior…

Merck & Co., Inc. (NYSE: MRK) reported its third quarter 2025 earnings results today. Total worldwide sales of $17.3 billion…

Merck (NYSE: MRK) reported its third quarter 2024 earnings results today. Sales grew 4% year-over-year to $16.7 billion. Excluding FX,…

Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported net profit for the second quarter of 2024, on an adjusted…

Merck (NYSE: MRK) reported sales of $16 billion for the third quarter of 2023, up 7% from the same period…

Merck (NYSE: MRK) reported second quarter 2023 earnings results today. Total worldwide sales were $15 billion, up 3% from the…

Merck & Co., Inc. (NYSE: MRK) Q1 2023 Earnings Call dated Apr. 27, 2023 Corporate Participants: Peter Dannenbaum — Vice President, Investor…

Merck & Co Inc (NYSE:MRK) Q4 2022 Earnings Call dated Feb. 02, 2023. Corporate Participants: Peter Dannenbaum — Vice President, Investor Relations…

Merck (NYSE: MRK) reported fourth quarter 2022 earnings results today. Sales increased 2% year-over-year to $13.8 billion. GAAP net income…